A composition for treating hiv comprising virus-like particles
作者： Pin-Fang Lin , Brian Vincent Mcauliffe , Hsu-Tso Ho , Li Fan
DOI:
关键词:
摘要: This invention provides an HTV VLP having one or more mutations in (gp160). The HIV may be administered to a patient alone, combination with additional VLPs gp (160), attachment inhibitor and (160).
lens.org 参考文章(6)
Shan-Ming Kuang, Chong-Hui Gu, Jaquan Kalani Levons, Qi Gao, Feng Qian, Chiajen Lai, Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4] triazol-1-yl}-1h-pyrrolo[2,3-c]pyridin-3-yl}-ethane-1,2-dione ,(2005)
Nicholas A. Meanwell, John F. Kadow, Edward H. Ruediger, Daniel H. Deon, Carol Bachand, Kap-Sun Yeung, Zhongxing Zhang, Clint A. James, Zhiwei Yin, Tao Wang, Zhilei Qui, Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides ,(2003)
Alicia Regueiro-Ren, Nicholas A. Meanwell, John D. Matiskella, John F. Kadow, Yasutsugu Ueda, Qiufen May Xue, Zhongxing Zhang, Zhiwei Yin, Tao Wang, Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives ,(2003)
John A. Bender, Zhongxing Zhang, Owen B. Wallace, Tao Wang, Nicholas A. Meanwell, Antiviral azaindole derivatives ,(2001)
Marie-Paule Kieny, Immunogenic compositions comprising soluble, non-cleavable, chimeric HIV-1 gp160-variants ,(1995)
Andrea Jegerlehner, Philippe Saudan, Gary Jennings, Martin Bachmann, Till Alexander Roehn, Hiv peptide conjugates and uses thereof ,(2006)